Product 1/16

 Previous 
 Return to the Product List 
 Next 

Biologics in Inflammatory Bowel Disease,

  • ISBN 9780323323253
  • Author: By Edward V. Loftus, Jr, MD
  • Publ Date: 2014-08-13
  • Edition:
  • Binding: Hardback

$165.22
Sale: $148.70
Save: 10% off + GST

Add to Cart:
By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications. In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.
Whilst every effort is made to keep pricing information up-to-date, prices and availability are subject to change without notice. Where prices or other details have changed from those listed on the website we will contact the customer and only proceed with the order after receiving acceptance of the revised pricing.
Your IP Address is: 3.144.34.110
Copyright © 2024 Medical Books. Powered by Zen Cart